Suppr超能文献

头孢呋辛酯治疗儿童急性中耳炎

Cefuroxime axetil in the treatment of acute otitis media in children.

作者信息

Syrogiannopoulos G A, Goumas P D, Haliotis F A, Lygatsikas C G, Spyropoulos C D, Beratis N G

机构信息

Department of Pediatrics, University of Patras, School of Medicine, Greece.

出版信息

J Chemother. 1992 Aug;4(4):221-4. doi: 10.1080/1120009x.1992.11739168.

Abstract

Cefuroxime axetil was evaluated for clinical efficacy and tolerance in the treatment of acute otitis media in children. Fifty-five children, 5.0 to 10.8 years, were randomly assigned to receive 250mg cefuroxime axetil every 12 hours or 50mg/kg/day amoxicillin in three divided doses. Both treatment schemes lasted for 10 days. Acute otitis media was diagnosed by the presence of erythema and/or opacity with bulging of the tympanic membrane. A tympanogram was obtained upon enrollment to the study, as well as within 2 days after completion of therapy. Fifty-one children completed the treatment protocol. The cure rate was 74.1% for cefuroxime axetil and 75.0% for amoxicillin. Clinical improvement was noted in 25.9% of children treated with cefuroxime axetil and in 25.0% of those treated with amoxicillin. There was no clinical failure in the two treatment groups. None of the children experienced relapse of acute otitis media during the month following completion of therapy. The findings indicate that cefuroxime axetil given twice daily has comparable efficacy to amoxicillin given three times daily in the treatment of children with acute otitis media.

摘要

对头孢呋辛酯治疗儿童急性中耳炎的临床疗效和耐受性进行了评估。55名年龄在5.0至10.8岁的儿童被随机分配,分别接受每12小时250mg头孢呋辛酯治疗,或50mg/kg/天阿莫西林分三次给药治疗。两种治疗方案均持续10天。急性中耳炎通过鼓膜红斑和/或浑浊伴鼓膜膨出进行诊断。在研究入组时以及治疗结束后2天内进行鼓室图检查。51名儿童完成了治疗方案。头孢呋辛酯的治愈率为74.1%,阿莫西林的治愈率为75.0%。接受头孢呋辛酯治疗的儿童中有25.9%有临床改善,接受阿莫西林治疗的儿童中有25.0%有临床改善。两个治疗组均无临床治疗失败情况。在治疗结束后的一个月内,没有儿童出现急性中耳炎复发。研究结果表明,在治疗儿童急性中耳炎方面,每日两次服用头孢呋辛酯与每日三次服用阿莫西林疗效相当。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验